Tate & Lyle publishes 2026 annual report

  • Tate & Lyle published its Annual Report 2026, flagging a tougher demand backdrop that weighed on performance as the year progressed.
  • Integration of CP Kelco completed, expanding the portfolio and scientific capabilities, with cost synergies hitting a US$50 million annualized run-rate ahead of plan.
  • Management accelerated actions to restore revenue growth, including tighter customer segmentation, faster rollout of solutions platforms, and US$10 million invested in generative AI tools.
  • Outlook for the year ending March 31, 2027 points to modest revenue growth, weighted to the second half, with EBITDA broadly flat before a roughly US$20 million capacity consolidation impact.
  • Board disclosed a conditional proposal from Ingredion for a possible cash offer valuing shares at up to 615 pence, including permitted dividends.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tate & Lyle plc published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.